Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today.
Total revenues inched up 1% year-over-year to $12.3 billion.
Net earnings attributable to BMS were $1.31 billion, or $0.64 per share, compared to $1.68 billion, or $0.83 per share, last year. Adjusted EPS decreased 29% to $1.46.
Bristol Myers Squibb expects full-year 2025 revenue to range between $46.5-47.5 billion and adjusted EPS to range between $6.35-6.65.
Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small commission, but it...
Advertising Disclosure: When you buy something by clicking links within this article, we may earn a small commission, but it...
Traders work on the floor at the New York Stock Exchange in New York City, U.S., Dec. 17, 2025. Brendan...
In This Article This article is presented by NREIG. Most real estate investors insure their properties based on what they...
Recently, I wrote about how AI has already replaced 50,000 jobs this year. I use AI practically every day myself. So...
NVIDIA’s CEO Jensen Huang says the rise of ChatGPT was the “iPhone moment of AI.” And now? It’s not just...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
